New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2016.12.010PMID 28012953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iron chelation therapy to prevent the manifestations of aceruloplasminemia

  2015cited by this paper
• Aceruloplasminemia

  2015cited by this paper
• Combination‐therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron‐loading in aceruloplasminaemia

  2015cited by this paper
• Aceruloplasminaemia: a rare but important cause of iron overload

  2015cited by this paper
• A man in his 50s with high ferritin levels and increasing cognitive impairment.

  2015cited by this paper
• Aceruloplasminemia presents as Type 1 diabetes in non‐obese adults: a detailed case series

  2015cited by this paper
• Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.

  2015cited by this paper
• Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score

  2014cited by this paper
• Aceruloplasminemia: una entidad a considerar en pacientes con anemia ferropénica

  2014cited by this paper
• Aceruloplasminaemia: A Family with a Novel Mutation and Long-Term Therapy with Deferasirox

  2014cited by this paper
• Aceruloplasminemia: An entity to consider in patients with anemia.

  2014cited by this paper
• Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation

  2010cited by this paper
• Central nervous system involvement in a rare genetic iron overload disorder.

  2010cited by this paper
• Aceruloplasminemia: A novel mutation in a family with marked phenotypic variability

  2008cited by this paper
• Aceruloplasminemia: a case report

  2008cited by this paper
• The Neurological Presentation of Ceruloplasmin Gene Mutations

  2008cited by this paper
• Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation

  2007cited by this paper
• A 70‐YEAR‐OLD MAN WITH EXTRAPYRAMIDAL SYMPTOMS, DEMENTIA AND HEMOSIDEROSIS

  2006cited by this paper
• Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.

  2005cited by this paper
• Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.

  2005cited by this paper
• MR imaging of cerebral cortical involvement in aceruloplasminemia.

  2005cited by this paper
• Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation

  2004cited by this paper
• Clinical, molecular, and PET study of a case of aceruloplasminaemia presenting with focal cranial dyskinesia

  2004cited by this paper
• Aceruloplasminemia, an inherited disorder of iron metabolism

  2003cited by this paper
• Aceruloplasminemia, an iron metabolic disorder

  2003cited by this paper
• Mechanisms of Copper Incorporation into Human Ceruloplasmin*

  2002cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use

  2002cited by this paper
• Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights.

  2002cited by this paper
• Hepatic iron overload in aceruloplasminaemia

  2000cited by this paper
• Familial dementia due to a frameshift mutation in the caeruloplasmin gene

  1996cited by this paper
• Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.

  1994cited by this paper

• Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population data

  2025cites this paper
• Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review

  2025cites this paper
• 46, XY disorders of sex development combined with aceruloplasminaemia: a case report and review of the literature

  2025cites this paper
• A Novel Mutation Related to Aceruloplasminemia with Mild Clinical Findings: A Case Report

  2024influential citation
• Neurodegeneration With Brain Iron Accumulation in a Case of Adult Aceruloplasminemia

  2024cites this paper
• Blood cytopenias as manifestations of inherited metabolic diseases: a narrative review

  2024cites this paper
• Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson’s Phenotype Development

  2023cites this paper
• A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report

  2022cites this paper
• Brain iron accumulation on MRI revealing aceruloplasminemia: a rare cause of simultaneous brain and systemic iron overload

  2022cites this paper
• Degenerative dementias: a question of syndrome or disease?

  2022cites this paper
• Congenital Atypical Microcytic Anemia Accompanied by Hyposideremia and Iron Overload

  2022cites this paper
• Iron Homeostasis in the CNS: An Overview of the Pathological Consequences of Iron Metabolism Disruption

  2022cites this paper
• Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders

  2021cites this paper
• Ceruloplasmin deletion in myelinating glial cells induces myelin disruption and oxidative stress in the central and peripheral nervous systems

  2021cites this paper
• Autosomal recessive adult onset ataxia

  2021cites this paper
• Parkinsonism and ataxia.

  2021cites this paper
• Novel ceruloplasmin gene mutation causing aceruloplasminemia with diabetes in a Chinese woman: a case report.

  2021cites this paper
• Dementia as a core clinical feature of a patient with aceruloplasminemia

  2021cites this paper
• MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study

  2021cites this paper
• Intracranial iron distribution and quantification in aceruloplasminemia: A case study.

  2020cites this paper
• [Aceruloplasminemia, a rare condition not to be overlooked].

  2020cites this paper
• Quantification of different iron forms in the aceruloplasminemia brain to explore iron-related neurodegeneration

  2020cites this paper
• Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria.

  2020cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports

  2020cites this paper
• New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson’s disease

  2020cites this paper
• Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis

  2020cites this paper
• Wilson disease

  2019cites this paper
• Degenerative dementias: A question of syndrome or disease?

  2019cites this paper
• Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis

  2019cites this paper
• Clinical relevance of heterozygosis for aceruloplasminemia

  2019cites this paper
• Aceruloplasminemia: Neurodegeneration with brain iron accumulation associated with psychosis

  2019cites this paper
• Aceruloplasminemia and putaminal cavitation.

  2018cites this paper
• Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.

  2018cites this paper
• Parkinson’s Disease and Metal Storage Disorders: A Systematic Review

  2018cites this paper
• Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.

  2018cites this paper
• Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia

  2017cites this paper